New diabetes drug candidate PATAS enters first human safety tests
NCT ID NCT07223333
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 32 times
Summary
This early-stage study is testing a new drug called PATAS in healthy volunteers to see if it is safe and how the body processes it. The goal is to gather initial safety data before testing it in people with Type 2 diabetes. About 56 healthy adults aged 18 to 55 will receive either a single dose of PATAS or a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medpace Clinical Pharmacology Unit
RECRUITINGCincinnati, Ohio, 45227, United States
Contact
-
Medpace Clinical Pharmaology Unit
RECRUITINGCincinnati, Ohio, 45227, United States
Conditions
Explore the condition pages connected to this study.